Stephanie Anover-Sombke

发表

Effector Cytokine Expression Expression in T Cells Thereby Limiting FOXP3 Inhibits Activation-Induced NFAT2

H. Ochs, T. Torgerson, I. Dozmorov, 2009 .

FOXP3 exon 2 controls Treg stability and autoimmunity

S. Ziegler, S. Janga, T. Torgerson, 2022, Science Immunology.

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

M. Leppert, H. Ochs, T. Torgerson, 2008, The Journal of allergy and clinical immunology.

STAT3 mutation in the original patient with Job's syndrome.

H. Ochs, T. Torgerson, E. Renner, 2007, The New England journal of medicine.

Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome

H. Ochs, T. Torgerson, E. Gambineri, 2018, Front. Immunol..

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

A. Schäffer, E. Gertz, A. Plebani, 2008, Blood.

FOXP3 Inhibits Activation-Induced NFAT2 Expression in T Cells Thereby Limiting Effector Cytokine Expression1

H. Ochs, T. Torgerson, I. Dozmorov, 2009, The Journal of Immunology.

FOXP 3 Inhibits Activation-Induced NFAT 2 Expression in T Cells Thereby Limiting Effector Cytokine Expression 1

H. Ochs, T. Torgerson, I. Dozmorov, 2009 .

variants in antibody deficiency syndromes TNFRSF13B distinguishing disease-causing from risk-increasing mutations in TNFRSF13B Relevance of biallelic versus monoallelic

Anna L. David, A. Schäffer, E. Gertz, 2009 .

Atypical presentation of IL-12 receptor beta1 deficiency with pneumococcal sepsis and disseminated nontuberculous mycobacterial infection in a 19-month-old girl born to nonconsanguineous US residents.

S. Holland, T. Torgerson, S. Rosenzweig, 2010, The Journal of allergy and clinical immunology.